Effects of a 2-y dietary weight-loss intervention on cholesterol metabolism in moderately obese men

American Journal of Clinical Nutrition

Volumn 94, Issue 5, 2011, Pages 1189-1195

  Leichtle, Alexander B ^a   Helmschrodt, Christin ^b   Ceglarek, Uta ^b   Shai, Iris ^c   Henkin, Yaakov ^d   Schwarzfuchs, Dan ^e   Golan, Rachel ^c   Gepner, Yftach ^c   Stampfer, Meir J ^f,g   Blüher, Matthias ^h   Stumvoll, Michael ^h   Thiery, Joachim ^b   Fiedler, Georg M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e NUCLEAR RESEARCH CENTER NEGEV   (Israel)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CAMPESTEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LANOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL;

ADULT; ARTICLE; CHOLESTEROL METABOLISM; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED CLINICAL TRIAL; DIET THERAPY; FOLLOW UP; HUMAN; INSULIN RESISTANCE; INTERVENTION STUDY; INTESTINE ABSORPTION; LOW CARBOHYDRATE DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; OBESITY; RANDOMIZED CONTROLLED TRIAL; UPREGULATION; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; BODY WEIGHT; CHOLESTEROL; DIET, REDUCING; HUMANS; LANOSTEROL; MALE; MIDDLE AGED; OBESITY; PHYTOSTEROLS; STATISTICS, NONPARAMETRIC; WEIGHT LOSS;

EID: 80054962856     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.018119     Document Type: Article

References (50)

1. Gylling H, Miettinen TA. Cholesterol absorption: influence of body weight and the role of plant sterols. Curr Atheroscler Rep 2005;7:466-71. (Pubitemid 43033773)
2. Santosa S, Varady KA, AbuMweis S, Jones PJ. Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist? Life Sci 2007;80(6):505-14. (Pubitemid 46038329)
3. Matthan NR, Lichtenstein AH. Approaches to measuring cholesterol absorption in humans. Atherosclerosis 2004;174:197-205. (Pubitemid 38597076)
4. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990;131:20-31. (Pubitemid 20014696)
5. Pihlajamäki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004;45:507-12. (Pubitemid 38337997)
6. Simonen PP, Gylling H, Miettinen TA. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes Res 2002;10:328-35. (Pubitemid 135688242)
7. Miettinen TA, Gylling H. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 2000;153:241-8.
8. Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr Metab Cardiovasc Dis 2006;16:13-21.
9. Miettinen TA, Gylling H. Effect of statins on noncholesterol sterol levels: implications for use of plant stanols and sterols. Am J Cardiol 2005;96(1A):40D-6D. (Pubitemid 40898169)
10. Miettinen TA, Gylling H. Cholesterol synthesis and absorption in coronary patients with lipid triad and isolated high LDL cholesterol in a 4S subgroup. Atherosclerosis 2003;168:343-9. (Pubitemid 36703334)
11. Miettinen TA, Gylling H. Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients. Atherosclerosis 2002;164:147-52. (Pubitemid 34773441)
12. Sudhop T, Gottwald BM, Von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 2002;51: 1519-21. (Pubitemid 36018822)
13. Rajaratnam RA, Gylling H, Miettinen TA. Cholesterol absorption, synthesis, and fecal output in postmenopausal women with and without coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:1650-5. (Pubitemid 34215586)
14. Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 1991;40:842-8.
15. Miettinen TA, Gylling H. Mortality and cholesterol metabolism in familial hypercholesterolemia. Long-term follow-up of 96 patients. Arteriosclerosis 1988;8:163-7. (Pubitemid 18090924)
16. Miettinen TA. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest 1980;10:27-35. (Pubitemid 10133847)
17. Simonen P, Gylling H, Miettinen TA. Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes. Clin Chim Acta 2002;316:55-61. (Pubitemid 34028188)
18. Gylling H, Miettinen TA. Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. Diabetes Care 1997;20:90-5. (Pubitemid 27020049)
19. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR,Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, et al. Weight loss with a lowcarbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008;359 (3):229-41. (Pubitemid 352008438)
20. Shai I, Spence JD, Schwarzfuchs D, Henkin Y, Parraga G, Rudich A, Fenster A, Mallett C, Liel-Cohen N, Tirosh A, et al. Dietary intervention to reverse carotid atherosclerosis. Circulation 2010;121(10): 1200-8.
21. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
22. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087-92. (Pubitemid 27274268)
23. Erez G, Tirosh A, Rudich A, et al. Phenotypic and genetic variation in leptin as determinants of weight regain. Int J Obes (Lond) 2011;35: 785-92.
24. Lembcke J, Ceglarek U, Fiedler GM, Baumann S, Leichtle A, Thiery J. Rapid quantification of free and esterified phytosterols in human serum using APPI-LC-MS/MS. J Lipid Res 2005;46:21-6. (Pubitemid 40066667)
25. Everitt B, Hothorn T, eds. A handbook of statistical analyses using R. 1 ed. Boca Raton, FL: Chapman & Hall, 2006.
26. Zhu D, Li Y, Li H. Multivariate correlation estimator for inferring functional relationships from replicated genome-wide data. Bioinformatics 2007;23:2298-305. (Pubitemid 47423868)
27. Gylling H, Hallikainen M, Kolehmainen M, Toppinen L, Pihlajamaki J, Mykkanen H, Agren JJ, Rauramaa R, Laakso M, Miettinen TA. Cholesterol synthesis prevails over absorption in metabolic syndrome. Transl Res 2007;149(6):310-6. (Pubitemid 46818162)
28. Hoenig MR, Sellke FW. Insulin resistance is associated with increased cholesterol synthesis, decreased cholesterol absorption and enhanced lipid response to statin therapy. Atherosclerosis 2010;211(1):260-5.
29. Weingartner O, Lutjohann D, Bohm M, Laufs U. Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk. Atherosclerosis 2010;210(2):362-5.
30. Cofan M, Escurriol V, Garcia-Otin AL, Moreno-Iribas C, Larranaga N, Sanchez MJ, Tormo MJ, Redondo ML, Gonzalez CA, Corella D, et al. Association of plasma markers of cholesterol homeostasis with metabolic syndrome components. A cross-sectional study. Nutr Metab Cardiovasc Dis (Epub ahead of print 27 May 2010).
31. Gylling H, Hallikainen M, Pihlajamaki J, Simonen P, Kuusisto J, Laakso M, Miettinen TA. Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study. J Lipid Res 2010;51(8):2422-7.
32. Ooi EM, Ng TW, Chan DC, Watts GF. Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes. Diabetes Res Clin Pract 2009;85:310-6.
33. Simonen P, Gylling H, Howard AN, Miettinen TA. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 2000;72:82-8. (Pubitemid 30441661)
34. Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism 2010;59:299-304.
35. Houweling AH, Vanstone CA, Trautwein EA, Duchateau GS, Jones PJ. Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched food. Eur J Clin Nutr 2009;63: 543-51.
36. Di Buono M, Hannah JS, Katzel LI, Jones PJ. Weight loss due to energy restriction suppresses cholesterol biosynthesis in overweight, mildly hypercholesterolemic men. J Nutr 1999;129:1545-8. (Pubitemid 29344602)
37. Angelin B, Backman L, Einarsson K, Eriksson L, Ewerth S. Hepatic cholesterol metabolism in obesity: activity of microsomal 3-hydroxy-3- methylglutaryl coenzyme A reductase. J Lipid Res 1982;23:770-3. (Pubitemid 13227210)
38. Zhao C, Dahlman-Wright K. Liver X receptor in cholesterol metabolism. J Endocrinol 2010;204:233-40.
39. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Kalboussi N, Ben Rejeb N, Nabli N, Ben Abdelaziz A, Boughazala E, Bouslama A. Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients. Metab Syndr Relat Disord 2010;8:515-22.
40. Vaverkova H, Karasek D, Novotny D, Jackuliakova D, Lukes J, Halenka M, Frohlich J. Apolipoprotein B versus LDL-cholesterol: association with other risk factors for atherosclerosis. Clin Biochem 2009;42:1246-51.
41. Faulds MH, Zhao C, Dahlman-Wright K. Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases. Curr Opin Pharmacol 2010;10:692-7.
42. Oosterveer MH, Grefhorst A, Groen AK, Kuipers F. The liver X receptor: control of cellular lipid homeostasis and beyond implications for drug design. Prog Lipid Res 2010;49:343-52.
43. Hu YW, Zheng L, Wang Q. Regulation of cholesterol homeostasis by liver X receptors. Clin Chim Acta 2010;411:617-25.
44. Basciano H, Miller A, Baker C, Naples M, Adeli K. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins. Am J Physiol Gastrointest Liver Physiol 2009;297:G323-32.
45. Teupser D, Baber R, Ceglarek U, Scholz M, Illig T, Gieger C, Holdt LM, Leichtle A, Greiser KH, Huster D, et al. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 2010;3(4):331-9.
46. Weingärtner O, Lutjohann D, Vanmierlo T, Muller S, Gunther L, Herrmann W, Bohm M, Laufs U, Herrmann M. Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. Chem Phys Lipids 2011; 164:451-6.
47. Lammert F, Wang DQ. New insights into the genetic regulation of intestinal cholesterol absorption. Gastroenterology 2005;129:718-34. (Pubitemid 41096656)
48. Gylling H, Hallikainen M, Pihlajamaki J, Agren J, Laakso M, Rajaratnam RA, Rauramaa R, Miettinen TA. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004;45:1660-5. (Pubitemid 39296205)
49. Berge KE, von Bergmann K, Lutjohann D, Guerra R, Grundy SM, Hobbs HH, Cohen JC. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002;43:486-94. (Pubitemid 34252279)
50. Gylling H, Kontula K, Koivisto UM, Miettinen HE, Miettinen TA. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact. Arterioscler Thromb Vasc Biol 1997;17:38-44. (Pubitemid 27057322)